Skip to main content

MetLife Investment Management, LLC

Position in ORGO — Organogenesis Holdings Inc.

CIK 1529735 Whippany, NJ

Position in ORGO

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$95,309
+$58,610 QoQ
Shares Held
39,222
+153.3% QoQ
Ownership
0.030%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#62
of 135 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ORGO Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

MetLife Investment Management, LLC holds $106,800,407 across 37 Drug Manufacturers - Specialty & Generic names. ORGO ranks #34 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ORGO

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $95,309 39,222
2026-03-31 $36,699 15,485
2025-12-31 $157,642 30,433
2025-09-30 $166,259 39,398
2025-06-30 $152,988 41,800
2025-03-31 $151,731 35,123
2024-12-31 $117,097 36,593
2024-09-30 $77,586 27,128
2024-06-30 $117,194 41,855
2024-03-31 $104,611 36,835
2023-12-31 $155,522 38,025
2023-09-30 $120,919 38,025
2023-06-30 $126,243 38,025
2023-03-31 $80,993 38,025
2022-12-31 $60,979 22,669
2022-09-30 $122,951 37,948
2022-06-30 $104,602 21,435
2022-03-31 $302,049 39,639
2021-12-31 $136,132 14,733
2021-09-30 $209,797 14,733
2021-06-30 $244,862 14,733
2021-03-31 $193,259 10,607